Ralcorp Holdings, Inc. (RAH) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts RAH Hot Sheet
Price: $89.98 --0%
Financial Fact:
Cost of goods sold: -1.04B
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Cost of goods sold: -1.04B
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Ralcorp Holdings, Inc. (NYSE: RAH) reported Q2 EPS of $0.72 vs. the analyst estimate of $0.85. Revenue for the quarter came in at $1.06 million versus the consensus estimate of $1.05 million.
Diluted Earnings per Share (EPS) in this year's second quarter were negatively impacted by amounts related to plant closures, provision for a legal settlement, merger and integration costs, and the accelerated amortization of intangible assets, partially offset by a mark-to-market gain on economic hedges.
Refrigerated Dough contributed approximately $.08 to adjusted diluted EPS for the quarter and is expected to add $.34 to $.36 to adjusted diluted EPS for the full year
For earnings history and earnings-related data on Ralcorp Holdings, Inc. (RAH) click here.
Diluted Earnings per Share (EPS) in this year's second quarter were negatively impacted by amounts related to plant closures, provision for a legal settlement, merger and integration costs, and the accelerated amortization of intangible assets, partially offset by a mark-to-market gain on economic hedges.
Refrigerated Dough contributed approximately $.08 to adjusted diluted EPS for the quarter and is expected to add $.34 to $.36 to adjusted diluted EPS for the full year
For earnings history and earnings-related data on Ralcorp Holdings, Inc. (RAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
- NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
